- Price
Supplier Type
- Manufacturer
- contract manufacturer
- custom synthesis
Supplier Region
- Gujarat(2)
- Maharashtra(1)
- Tamil Nadu(1)
Purity
- powder
- Pharmaceutical Secondary Standard
- ISOPAC?
- European Pharmacopoeia (EP) Reference Standard
- Certified Reference Material
- bulk package
- British Pharmacopoeia (BP) Reference Standard
- analytical standard
- A widely used anti-neoplastic agent that also displays immunosuppressant properties.
- 99%
- >98.0%(N)
- 98%
Package
- 1kg
- 5kg
- 10kg
- 25kg
- 1MT
- 25125kg and 1 MT
- 10mg
- 25mg
- 50mg
- 100mg
- 1g
- 5g
- 10g
- 25g
- 100g
- 18%
Cyclophosphamide monohydrate
- CAS:6055-19-2
- MF:C7H17Cl2N2O3P
- MW:279.1
- EINECS:200-015-4
- Melting point::
- 49-51 °C (lit.)
- Flash point::
- >230 °F
- storage temp. :
- 2-8°C
- solubility :
- H2O: 0.1 g/mL, clear, colorless
- form :
- Crystals or Crystalline Powder
- color :
- White to almost white
- Water Solubility :
- 40 g/L
- Merck :
- 14,2747
- BRN :
- 8167897
- Stability::
- Hygroscopic
- InChIKey:
- PWOQRKCAHTVFLB-UHFFFAOYSA-N
- Symbol(GHS)
GHS06,GHS08
- Signal word
- Danger
- Hazard statements
- H301-H340-H350-H360FD
- Precautionary statements
- P202-P264-P270-P280-P301+P310-P405
Cyclophosphamide hydrate 6055-19-2
Cyclophosphamide hydrate 6055-19-2
Cyclophosphamide hydrate 6055-19-2
Cyclophosphamide hydrate 6055-19-2
Inquiry
Cyclophosphamide monohydrate >98% (HPLC) 6055-19-2
1week